Literature DB >> 16434816

Four cases of Kawasaki syndrome complicated with myocarditis.

Hideki Yoshikawa1, Yuichi Nomura, Kiminori Masuda, Daisuke Hazeki, Keiko Yotsumoto, Michiko Arata, Akira Kamenosono, Sadamitsu Yanagi, Masao Yoshinaga, Yoshifumi Kawano.   

Abstract

BACKGROUND: Myocarditis frequently occurs in the acute phase of Kawasaki syndrome (KS), and a few severe cases have been reported. Four cases of myocarditis in KS required additional catecholamine treatment because of severe left ventricular dysfunction (LVD). CASE REPORTS: Three cases were relatively older children and 2 cases were complicated with encephalopathy. All 4 developed coronary artery abnormalities during convalescence. There was 1 case of LVD because of prolonged severe inflammation prior to administration of intravenous immunoglobulin (IVIG). The remaining 3 patients had normal values for ejection fraction before the administration of IVIG but decreased values (42-51%) and increased C-reactive protein levels after IVIG administration. These cases demonstrate an association between myocarditis in KS and severe or worsened inflammation.
CONCLUSIONS: Even with prior normal echocardiography, careful observation of cardiac function may be necessary for patients with KS, especially older children, when inflammation deteriorates after administration of IVIG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434816     DOI: 10.1253/circj.70.202

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  12 in total

1.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

2.  Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients.

Authors:  D Micheloud; M Calderón; M Caparrros; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2007-07       Impact factor: 19.103

3.  Evaluation of left ventricular systolic strain in children with Kawasaki disease.

Authors:  Qiu-Qin Xu; Yue-Yue Ding; Hai-Tao Lv; Wan-Ping Zhou; Ling Sun; Jie Huang; Wen-Hua Yan
Journal:  Pediatr Cardiol       Date:  2014-05-25       Impact factor: 1.655

4.  Shock: an unusual presentation of Kawasaki disease.

Authors:  Farah Thabet; Hend Bafaqih; Suleiman Al-Mohaimeed; Mariam Al-Hilali; Wafaa Al-Sewairi; May Chehab
Journal:  Eur J Pediatr       Date:  2011-02-24       Impact factor: 3.183

5.  Symptomatic myocarditis in Kawasaki disease.

Authors:  Pooja Aggarwal; Deepti Suri; Nidhi Narula; Rohit Manojkumar; Surjit Singh
Journal:  Indian J Pediatr       Date:  2011-08-24       Impact factor: 1.967

6.  Kawasaki disease complicated with reversible splenial lesion and acute myocarditis.

Authors:  Shinji Itamura; Masahiro Kamada; Naomi Nakagawa
Journal:  Pediatr Cardiol       Date:  2011-03-06       Impact factor: 1.655

7.  Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy.

Authors:  Vikas Suri; Subhash Varma; Kiran Joshi; Pankaj Malhotra; Savita Kumari; Sanjay Jain
Journal:  Rheumatol Int       Date:  2009-08-21       Impact factor: 2.631

8.  B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.

Authors:  Satoru Iwashima; Takamichi Ishikawa
Journal:  World J Pediatr       Date:  2013-01-18       Impact factor: 2.764

Review 9.  The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease.

Authors:  Sophie Mavrogeni; George Papadopoulos; Tarique Hussain; Amedeo Chiribiri; Rene Botnar; Gerald F Greil
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-15       Impact factor: 2.357

Review 10.  Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.

Authors:  Nagib Dahdah; Anne Fournier
Journal:  Diagnostics (Basel)       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.